Summit Therapeu ADR (SMMT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 04-2019 | 01-2019 | 10-2018 | 07-2018 | 04-2018 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -6,361 | 6,675 | 14,214 | 27,092 | -9,325 |
| Depreciation Amortization | 457 | 1,510 | 1,109 | 761 | 392 |
| Accounts receivable | 5,289 | -2,943 | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | -2,641 | 123 | -4,798 | -3,142 | 4,151 |
| Other Working Capital | 1,270 | -51,772 | -51,029 | -48,211 | -1,037 |
| Other Operating Activity | 3,808 | 10,858 | 11,473 | -454 | -3,861 |
| Operating Cash Flow | $1,823 | $-35,549 | $-29,031 | $-23,954 | $-9,680 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -5 | -158 | -73 | -67 | -34 |
| Purchase Sale Intangibles | N/A | -8 | -7 | -7 | -7 |
| Other Investing Activity | 3 | -257 | -3 | -4 | -6 |
| Investing Cash Flow | $-3 | $-415 | $-75 | $-71 | $-40 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 1 | 46,103 | 19,593 | 20,094 | 20,763 |
| Other Financing Activity | -116 | -1,742 | -1,113 | -1,142 | -1,180 |
| Financing Cash Flow | $-115 | $44,361 | $18,480 | $18,952 | $19,583 |
| Exchange Rate Effect | 199 | 567 | 1,469 | 1,117 | 565 |
| Beginning Cash Position | 35,101 | 26,669 | 26,080 | 26,750 | 27,642 |
| End Cash Position | 37,005 | 35,633 | 16,923 | 22,794 | 38,070 |
| Net Cash Flow | $1,904 | $8,963 | $-9,157 | $-3,956 | $10,428 |
| Free Cash Flow | |||||
| Operating Cash Flow | 1,823 | -35,549 | -29,031 | -23,954 | -9,680 |
| Capital Expenditure | -5 | -158 | -73 | -67 | -34 |
| Free Cash Flow | 1,818 | -35,707 | -29,103 | -24,020 | -9,714 |